Browse Arkansas Code titles and sections
34 U.S.C. § 10702 — Applications
Federal law — U.S. Code and appendices · legal_authorities
Page 211
TITLE 34—CRIME CONTROL AND LAW ENFORCEMENT
§ 10702
monitoring program to collect and analyze
data related to the prescribing of schedules II,
III, and IV controlled substances through a
centralized database administered by an au-
thorized State agency, which includes track-
ing the dispensation of such substances, and
providing for interoperability and data shar-
ing with each other such program in each
other State, and with any interstate entity
that shares information between such pro-
grams.
(7) Developing, implementing, or expanding
a program to prevent and address opioid abuse
by juveniles.
(8) Developing, implementing, or expanding
a program (which may include demonstration
projects) to utilize technology that provides a
secure container for prescription drugs that
would prevent or deter individuals, particu-
larly adolescents, from gaining access to
opioid medications that are lawfully pre-
scribed for other individuals.
(9) Developing, implementing, or expanding
a prescription drug take-back program.
(10) Developing, implementing, or expanding
an integrated and comprehensive opioid abuse
response program.
(b) Contracts and subawards
A State, unit of local government, or Indian
tribe may, in using a grant under this sub-
chapter for purposes authorized by subsection
(a), use all or a portion of that grant to contract
with, or make one or more subawards to, one or
more—
(1) local or regional organizations that are
private and nonprofit, including faith-based
organizations;
(2) units of local government; or
(3) tribal organizations.
(c) Program assessment component; waiver
(1) Program assessment component
Each program funded under this subchapter
shall contain a program assessment compo-
nent, developed pursuant to guideli
Source: Supplied 2024 U.S. Code historical extraction · 34 U.S.C. § 10702
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: b12539ac47ad8517375ea5b068abd6b4589c63b5de407ccde9711cff478a18a0. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-7764b9eac0bff70ebf5fa53a
Source file: Laws/federal/codes/united-states-code-2024/title-34/section-10702-applications--4f92656a5d.md
Pages: Not recorded – Not recorded
Passage SHA-256: 207437814950729a083437ac9ddc8ef70a2de73ed5da131e931880fe8dd77881
Source location: USCODE-2024-title34-subtitleI-chap101-subchapXXXVIII-sec10702.pdf
Stored source content
Page 211
TITLE 34—CRIME CONTROL AND LAW ENFORCEMENT
§ 10702
monitoring program to collect and analyze
data related to the prescribing of schedules II,
III, and IV controlled substances through a
centralized database administered by an au-
thorized State agency, which includes track-
ing the dispensation of such substances, and
providing for interoperability and data shar-
ing with each other such program in each
other State, and with any interstate entity
that shares information between such pro-
grams.
(7) Developing, implementing, or expanding
a program to prevent and address opioid abuse
by juveniles.
(8) Developing, implementing, or expanding
a program (which may include demonstration
projects) to utilize technology that provides a
secure container for prescription drugs that
would prevent or deter individuals, particu-
larly adolescents, from gaining access to
opioid medications that are lawfully pre-
scribed for other individuals.
(9) Developing, implementing, or expanding
a prescription drug take-back program.
(10) Developing, implementing, or expanding
an integrated and comprehensive opioid abuse
response program.
(b) Contracts and subawards
A State, unit of local government, or Indian
tribe may, in using a grant under this sub-
chapter for purposes authorized by subsection
(a), use all or a portion of that grant to contract
with, or make one or more subawards to, one or
more—
(1) local or regional organizations that are
private and nonprofit, including faith-based
organizations;
(2) units of local government; or
(3) tribal organizations.
(c) Program assessment component; waiver
(1) Program assessment component
Each program funded under this subchapter
shall contain a program assessment compo-
nent, developed pursuant to guidelines estab-
lished by the Attorney General, in coordina-
tion with the National Institute of Justice.
(2) Waiver
The Attorney General may waive the re-
quirement of paragraph (1) with respect to a
program if, in the opinion of the Attorney
General, the program is not of sufficient size
to justify a full program assessment.
(d) Administrative costs
Not more than 10 percent of a grant made
under this subchapter may be used for costs in-
curred to administer such grant.
(e) Period
The period of a grant made under this sub-
chapter may not be longer than 4 years, except
that renewals and extensions beyond that period
may be granted at the discretion of the Attor-
ney General.
(f) Rural pilot program
(1) In general
The pilot program described under this sub-
section shall make grants to rural areas to im-
plement community response programs to re-
duce opioid overdose deaths. Grants issued
under this subsection shall be jointly operated
by units of local government, in collaboration
with public safety and public health agencies
or public safety, public health and behavioral
health collaborations. A community response
program under this subsection shall identify
gaps in community prevention, treatment, and
recovery services for individuals who encoun-
ter the criminal justice system and shall es-
tablish treatment protocols to address identi-
fied shortcomings. The Attorney General,
through the Office of Justice Programs, shall
increase the amount provided as a grant under
this section for a pilot program by no more
than five percent for each of the two years fol-
lowing certification by the Attorney General
of the submission of data by the rural area on
the prescribing of schedules II, III, and IV con-
trolled substances to a prescription drug mon-
itoring program, or any other centralized
database administered by an authorized State
agency, which includes tracking the dispensa-
tion of such substances, and providing for
interoperability and data sharing with each
other such program (including an electronic
health records system) in each other State,
and with any interstate entity that shares in-
formation between such programs.
(2) Rules of construction
Nothing in this subsection shall be con-
strued to—
(A) direct or encourage a State to use a
specific interstate data sharing program; or
(B) limit or prohibit the discretion of a
prescription drug monitoring program for
interoperability connections to other pro-
grams (including electronic health records
systems, hospital systems, pharmacy dis-
pensing systems, or health information ex-
changes).
(Pub. L. 90–351, title I, § 3021, as added Pub. L.
114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat.
711; amended Pub. L. 117–250, § 2, Dec. 20, 2022, 136
Stat. 2352.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 3797ff of
Title 42, The Public Health and Welfare, prior to edi-
torial reclassification and renumbering as this section.
AMENDMENTS
2022—Subsec. (a)(1)(H). Pub. L. 117–250, § 2(1), added
subpar. (H).
Subsec. (f). Pub. L. 117–250, § 2(2), added subsec. (f).
§ 10702. Applications
To request a grant under this subchapter, the
chief executive officer of a State, unit of local
government, or Indian tribe shall submit an ap-
plication to the Attorney General at such time
and in such form as the Attorney General may
require. Such application shall include the fol-
lowing:
(1) A certification that Federal funds made
available under this subchapter will not be
used to supplant State, local, or tribal funds,
Page 212
TITLE 34—CRIME CONTROL AND LAW ENFORCEMENT
§ 10703
1 See References in Text note below.
but will be used to increase the amounts of
such funds that would, in the absence of Fed-
eral funds, be made available for the activities
described in section 10701(a) of this title.
(2) An assurance that, for each fiscal year
covered by an application, the applicant shall
maintain and report such data, records, and
information (programmatic and financial) as
the Attorney General may reasonably require.
(3) A certification, made in a form accept-
able to the Attorney General and executed by
the chief executive officer of the applicant (or
by another officer of the applicant, if qualified
under regulations promulgated by the Attor-
ney General), that—
(A) the activities or services to be funded
by the grant meet all the requirements of
this subchapter;
(B) all the information contained in the
application is correct;
(C) there has been appropriate coordina-
tion with affected agencies; and
(D) the applicant will comply with all pro-
visions of this subchapter and all other ap-
plicable Federal laws.
(4) An assurance that the applicant will
work with the Drug Enforcement Administra-
tion to develop an integrated and comprehen-
sive strategy to address opioid abuse.
(Pub. L. 90–351, title I, § 3022, as added Pub. L.
114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat.
712.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 3797ff–1 of
Title 42, The Public Health and Welfare, prior to edi-
torial reclassification and renumbering as this section.
§ 10703. Review of applications
The Attorney General shall not finally dis-
approve any application (or any amendment to
that application) submitted under this sub-
chapter without first affording the applicant
reasonable notice of any deficiencies in the ap-
plication and an opportunity for correction of
any such deficiencies and reconsideration.
(Pub. L. 90–351, title I, § 3023, as added Pub. L.
114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat.
713.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 3797ff–2 of
Title 42, The Public Health and Welfare, prior to edi-
torial reclassification and renumbering as this section.
§ 10704. Equitable distribution of funds
In awarding grants under this subchapter, the
Attorney General shall distribute funds in a
manner that—
(1) equitably addresses the needs of under-
served populations, including rural and tribal
communities; and
(2) focuses on communities that have been
disproportionately impacted by opioid abuse
as evidenced in part by—
(A) high rates of primary treatment ad-
missions for heroin and other opioids;
(B) high rates of drug poisoning deaths
from heroin and other opioids; and
(C) a lack of accessibility to treatment
providers and facilities and to emergency
medical services.
(Pub. L. 90–351, title I, § 3024, as added Pub. L.
114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat.
713.)
Editorial Notes
CODIFICATION
Section was formerly classified to section 3797ff–3 of
Title 42, The Public Health and Welfare, prior to edi-
torial reclassification and renumbering as this section.
§ 10705. Definitions
In this subchapter:
(1) The term ‘‘first responder’’ includes a
firefighter, law enforcement officer, para-
medic, emergency medical technician, or
other individual (including an employee of a
legally organized and recognized volunteer or-
ganization, whether compensated or not), who,
in the course of his or her professional duties,
responds to fire, medical, hazardous material,
or other similar emergencies.
(2) The term ‘‘medication-assisted treat-
ment’’ means the use of medications approved
by the Food and Drug Administration for the
treatment of opioid abuse.
(3) The term ‘‘opioid’’ means any drug, in-
cluding heroin, having an addiction-forming or
addiction-sustaining liability similar to mor-
phine or being capable of conversion into a
drug having such addiction-forming or addic-
tion-sustaining liability.
(4) The term ‘‘schedule II, III, or IV con-
trolled substance’’ means a controlled sub-
stance that is listed on schedule II, schedule
III, or schedule IV of section 812(c) of title 21.
(5) The terms ‘‘drug’’ and ‘‘device’’ have the
meanings given those terms in section 321 of
title 21.
(6) The term ‘‘criminal justice agency’’
means a State, local, or tribal—
(A) court;
(B) prison;
(C) jail;
(D) law enforcement agency; or
(E) other agency that performs the admin-
istration of criminal justice, including pros-
ecution, pretrial services, and community
supervision.
(7) The term ‘‘tribal organization’’ has the
meaning given that term in section 5304 of
title 25.
(8) The term ‘‘State substance abuse agen-
cy’’ has the meaning given that term in sec-
tion 290bb–1(r)(6) 1 of title 42.
(Pub. L. 90–351, title I, § 3025, as added Pub. L.
114–198, title II, § 201(a)(1), July 22, 2016, 130 Stat.
713.)
Editorial Notes
REFERENCES IN TEXT
Section 290bb–1(r)(6) of title 42, referred to in par. (8),
was redesignated section 290bb–1(r)(5) of title 42 by Pub.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
To request a grant under this subchapter, the chief executive officer of a State, unit of local government, or Indian tribe shall submit an application to the Attorney General at such time and in such form as the Attorney General may require. Such application shall include the following:
(1) A certification that Federal funds made available under this subchapter will not be used to supplant State, local, or tribal funds, but will be used to increase the amounts of such funds that would, in the absence of Federal funds, be made available for the activities described in [section 10701(a) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title34-section10701/a&num=0&edition=prelim).
(2) An assurance that, for each fiscal year covered by an application, the applicant shall maintain and report such data, records, and information (programmatic and financial) as the Attorney General may reasonably require.
(3) A certification, made in a form acceptable to the Attorney General and executed by the chief executive officer of the applicant (or by another officer of the applicant, if qualified under regulations promulgated by the Attorney General), that—
(A) the activities or services to be funded by the grant meet all the requirements of this subchapter;
(B) all the information contained in the application is correct;
(C) there has been appropriate coordination with affected agencies; and
(D) the applicant will comply with all provisions of this subchapter and all other applicable Federal laws.
(4) An assurance that the applicant will work with the Drug Enforcement Administration to develop an integrated and comprehensive strategy to address opioid abuse.
Source: Supplied U.S. Code snapshot — release unconfirmed · 34 U.S.C. § 10702
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.